Page last updated: 2024-08-26

sr141716 and Anaplastic Astrocytoma

sr141716 has been researched along with Anaplastic Astrocytoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Corbacho, C; de Ceballos, ML; Galve-Roperh, I; Gomez del Pulgar, T; Guzmán, M; Huffman, JW; Ramón y Cajal, S; Rueda, D; Sánchez, C; Velasco, G	1

Other Studies

1 other study(ies) available for sr141716 and Anaplastic Astrocytoma

Article	Year
Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. Cancer research, 2001, Aug-01, Volume: 61, Issue:15 Topics: Animals; Antineoplastic Agents; Apoptosis; Astrocytoma; Benzoxazines; Brain Neoplasms; Camphanes; Cannabinoids; Cell Division; Ceramides; Glioma; Growth Inhibitors; Humans; Mice; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2001

Article

Year

Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.

Cancer research, 2001, Aug-01, Volume: 61, Issue:15

Topics: Animals; Antineoplastic Agents; Apoptosis; Astrocytoma; Benzoxazines; Brain Neoplasms; Camphanes; Cannabinoids; Cell Division; Ceramides; Glioma; Growth Inhibitors; Humans; Mice; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2001